 | The 131st Annual Meeting (November 15-19, 2003) of APHA |
|
| The 131st Annual Meeting (November 15-19, 2003) of APHA |
Amelie G. Ramirez, DrPH1, Eliseo J Perez-Stable, MD2, Kipling Gallion, MA1, Fabiola Aparicio-ting, MPH3, and Armin Weinberg, PhD1. (1) Dept. of Medicine, Baylor College of Medicine, 8207 Callaghan Rd., Suite 110, San Antonio, TX 78230, 210 348 0255, aramirez@bcm.tmc.edu, (2) Department of General Internal Medicine, University of California San Francisco, 3333 California Street, Suite 335, San Francisco, CA 94143, (3) Medicine, Baylor College of Medicine, 8207 callaghan, #110, San Antonio, TX 78230
A survey (N=746) compared Hispanic and non-Hispanic physician knowledge, attitudes and practices regarding clinical trial participation. Two thousand physicians (<65 years old) from the American Medical Association were randomly selected from 6 states (Texas, California, Illinois, New York/ New Jersey, and Florida), who self-identify as Latino/Hispanic or White/Caucasian, and who were general internist, family physician or gynecologist. New York and New Jersey were treated as one region and the total sample was stratified to have equal numbers by ethnicity and in each of the five regions as well as equal numbers of general internists and family physicians by region (75 each) and fewer gynecologists (50 each). All medical oncologists, self-identified as Latino, were included in the sample. These are “additional” potential respondents to the sample size of 2000. The mailed survey package included 1) a cover letter introducing the study, providing contact information, and emphasizing that survey responses are confidential and not linked to their names in any way; 2) a postcard reminder for non-respondents; 3) a $5 incentive for completion of the survey and 4) the survey. Results indicate, that in general, most physicians, whether Hispanic or non-Hispanic didn’t discuss the clinical trials with their patients. Overall, Hispanic and non-Hispanic physicians have similar attitudes and behaviors regarding clinical trials. Other items of variance will be presented during the meeting. With such low participation rates among all population groups but especially Hispanics and other minorities, increasing awareness of trials and ways to bridge this subject with their patients is needed.
Learning Objectives:
Keywords: Physicians, Clinical Trails
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.